We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03002805
Recruitment Status : Unknown
Verified August 2019 by CBA Research.
Recruitment status was:  Recruiting
First Posted : December 26, 2016
Last Update Posted : August 19, 2019
Sponsor:
Information provided by (Responsible Party):
CBA Research

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
Recruitment Status : Unknown
Estimated Primary Completion Date : September 2020
Estimated Study Completion Date : September 2020
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):